| View |
|
DR-XY36847
|
Sodium bicarbonate + Sodium citrate + Citric Acid + Tartaric Acid
|
Ural
|
1760 mg/ 630 mg/ 720 mg/ 890 mg per sachet
|
Effervescent Granules
|
Urinary and Gastric Alkalinizer
|
Aspen Pharma Pty. Ltd.
|
Australia
|
Renewal
|
05 October 2024
|
21 October 2029
|
| View |
|
DR-XY36848
|
Clopidogrel
|
Hemaflow
|
75mg
|
Film-Coated Tablet
|
Antithrombotic
|
Hovid Berhad
|
Malaysia
|
Renewal
|
10 May 2024
|
21 October 2029
|
| View |
|
DR-XY36855
|
Escitalopram (as oxalate)
|
Jovia
|
10 mg
|
Film-Coated Tablet
|
Antidepressant/Selective Serotonin Reuptake Inhibitor (SSRI)
|
Bilim Ilac Sanayii Ve Ticaret A.S.
|
Turkey
|
Renewal
|
04 September 2024
|
21 October 2029
|
| View |
|
DR-XY36860
|
Multivitamins
|
Nervron
|
300 mg/100 mg/100 mcg
|
Capsule
|
Vitamins
|
Ashford Pharmaceutical Laboratories
|
Philippines
|
Renewal
|
20 October 2024
|
23 October 2029
|
| View |
|
DR-XY36867
|
Cefotaxime (as Sodium)
|
Cefotax
|
1g
|
Pfi (I.M. / I.V.)
|
Antibacterial (Cephalosphorins)
|
Singapore Pharmawealth Lifesciences, Inc.
|
Philippines
|
Renewal
|
19 December 2023
|
04 January 2029
|
| View |
|
DR-XY36873
|
Phenylephrine hydrochloride + Brompheniramine maleate
|
Unbranded
|
12.5 mg/4 mg per 5 mL
|
Syrup
|
Decongestant / Antihistamine
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 July 2024
|
26 October 2029
|
| View |
|
DR-XY36892
|
CEFUROXIME (AS AXETIL)
|
CEFUROX
|
250 mg
|
Film-Coated Tablet
|
ANTIBACTERIAL (CEPHALOSPORIN)
|
Medicaids Pakistan Pvt. Ltd.
|
Pakistan
|
Renewal
|
09 October 2024
|
03 November 2029
|
| View |
|
DR-XY36897
|
Mecobalamin
|
Neuromet
|
500 mcg
|
Capsule
|
Hematinics
|
Samchun Dang Pharm. Co. Ltd.
|
Korea
|
Automatic Renewal
|
08 September 2022
|
09 November 2027
|
| View |
|
DR-XY3691
|
Chlorphenamine Maleate
|
Metromine
|
2mg/ 5 mL
|
Syrup
|
Antihistamine (H1-Receptor Antagonist)
|
Marnets Pharma Corporation
|
Philippines
|
Automatic Renewal
|
03 August 2021
|
03 September 2026
|
| View |
|
DR-XY36929
|
Proparacaine Hydrochloride
|
Primax
|
5mg/ mL (0.5%)
|
Ophthalmic Solution (Eye Drops)
|
LOCAL ANAESTHETIC
|
Laboratories Ashford Limitida
|
China
|
Automatic Renewal
|
07 December 2021
|
05 November 2026
|
| View |
|
DR-XY36935
|
Ketoralac Trometamol
|
Xevolac
|
30mg/mL
|
Solution For Injection (IM/IV)
|
-
|
PT Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
15 November 2022
|
06 November 2026
|
| View |
|
DR-XY3694
|
Lidocaine hydrochloride + Prilocaine hydrochloride
|
Emla®
|
25mg/ 25mg (5%)
|
Cream
|
Local Anesthesia
|
Recipharm Karlskoga AB
|
Sweden
|
Renewal
|
01 June 2021
|
01 August 2026
|
| View |
|
DR-XY36953
|
Cefuroxime (As Axetil)
|
Furcef
|
125mg/5mL
|
Granules For Suspension
|
-
|
Lloyd Laboratories, Inc.
|
Philippines
|
-
|
10 December 2020
|
11 November 2025
|
| View |
|
DR-XY36957
|
Piracetam
|
Zystam
|
800 mg
|
Film-Coated Tablet
|
Nootropic
|
The Schazoo Pharmaceutical Laboratories (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
12 October 2024
|
11 November 2029
|
| View |
|
DR-XY36960
|
Adapalene + Benzoyl Peroxide
|
Epiduo
|
1 mg/25 mg per gram (0.1%/ 2.5% w/w)
|
Gel
|
-
|
Laboratories Galderma
|
France
|
Initial (Variation)
|
05 July 2022
|
10 November 2027
|
| View |
|
DR-XY36974
|
Levocetrizine dihyrdrochloride
|
Allerzet
|
5 mg
|
Film-Coated Tablet
|
Antihistamine (Piperazine Derivative)
|
Amherst Laboratories, Inc.
|
Philippines
|
Renewal
|
05 August 2022
|
19 September 2027
|
| View |
|
DR-XY37012
|
Clonazepam
|
Rivotril
|
2 mg
|
Tablet
|
-
|
Recipharm Leganes S.L.U.
|
Spain
|
Initial (Variation)
|
09 August 2022
|
09 August 2027
|
| View |
|
DR-XY37015
|
Levofloxacin (as hemihydrate)
|
Loxeva
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Fluoroquinolone)
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
12 May 2024
|
18 November 2029
|
| View |
|
DR-XY37019
|
Rifampicin + Isoniazid + Pyrazinamide + Ethambutol
|
Unbranded
|
150mg/ 75mg/ 400mg/ 275mg
|
Tablet
|
Antituberculosis
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
17 May 2024
|
18 November 2029
|
| View |
DR-XY37022_PI_01.pdf
|
DR-XY37022
|
Losartan Potassium
|
Wilopres
|
50 mg
|
Film Coated Tablet
|
Angiotensin II Receptor Blocker
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
15 September 2024
|
26 November 2029
|